Burchfield, MD, and other participants discussed their experiences with the frontline combination regimens for advanced renal ...

CEL-SCI (CVM) announced that a third-party study published on March 6 in JAMA Oncology provided data that support Multikine’s use as a ...

While immunotherapy is a major treatment option, it does not work for everyone ... blood that behaved differently in patients receiving nivolumab alone versus those receiving the combination ...

An oncologist from Atrium Health outlines how saving time administering immunotherapy could have far-reaching benefits.

Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of Head and Neck Patients.

Georgina V. Long, MD, MSc, discussed the long-term follow-up data for the combination of adjuvant dabrafenib and trametinib ...

Two years after Neil Armstrong walked on the Moon, US president Richard Nixon declared a new frontier in American scientific ...

Curve, the digital wallet that saves you money, announced today it has secured a £37M investment led by Hanaco Ventures, with participation of existing shareholders such as Fuel Ventures, IDC, Outward ...

Coherus BioSciences, Inc. ( NASDAQ: CHRS) Q4 2024 Earnings Conference Call March 10, 2025 5:00 PM ET Jodi Sievers - Head of IR Denny Lanfear - CEO Paul Reider - CCO Sameer Goregaoker - SVP, ...